Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Blogs » ED Push » Kaiser Permanente Program Slashes ‘Door to Needle’ Time for Stroke Patients

    ED Push
    ED Push RSS FeedRSS

    edpush-webheader-rm

    Free Monthly News from the Award Winning Publisher of:

    • Emergency Medicine Reports
    • Trauma Reports
    • Critical Care Alert
    • ED Management
    • ED Legal Letter
    • Pediatric Emergency Medicine Reports
    • EM Reports' Study Guide 2018
    • STROKE: The Cutting Edge: 2017
    • Pediatric Trauma 2018
    • STEMI Watch 2018
     

     

    Kaiser Permanente Program Slashes ‘Door to Needle’ Time for Stroke Patients

    January 4, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share
    By Brenda Mooney

    Improving “door to needle time” is critical in treating stroke at emergency departments. Now, Kaiser Permanente hospitals in Northern California have developed a way to treat stroke patients with clot-busting medication at more than twice the national average speed.

    An article in the journal Stroke details the effect of regionwide adoption of an integrated telemedicine program. Kaiser Permanente researchers tout the study as one of the first to prove that standardized treatment protocols and telemedicine in a large, integrated hospital system can significantly reduce time to acute ischemic stroke treatment with intravenous r-tPA.

    “When a stroke happens, minutes matter,” explained lead author Mai Nguyen-Huynh, MD, MAS, vascular neurologist and research scientist with the Kaiser Permanente Division of Research. “Faster treatment with intravenous r-tPA, which dissolves the stroke-causing clot and restores blood flow to the brain, is strongly associated with better functional outcomes for stroke patients.”

    While national guidelines call for door-to-needle times of less than an hour for intravenous r-tPA, in reality fewer than 30% of acute ischemic stroke patients in the United States are currently being treated within this window, recent research suggests.

    At Kaiser Permanente's 21 Northern California hospitals, however, 87% of stroke patients were treated in 60 minutes or less, 73% in 45 minutes or less, and 41% in less than 30 minutes. In fact, the article points out, the average treatment time for intravenous r-tPA was 34 minutes at those facilities.

    The key, according to study authors, is the EXpediting the PRocess of Evaluating and Stopping Stroke (EXPRESS) program. As part of that, all Kaiser Permanente EDs in Northern California were provided with telestroke carts, which include a video camera and access to scans and tests results; that enabled a stroke specialist to conduct each patient's neurologic physical exam remotely.

    The protocol assigns specific tasks to each member of the healthcare response team:

    • Paramedics provide advance notification to the ED that a stroke patient is en route.
    • A stroke alert notifies a neurologist, who meets the patient upon arrival, in person or via video, to coordinate treatment.
    • Pharmacists prepare clot-busting medication early, so it is ready to be administered when required.
    • A radiologist evaluates neuroimaging and confirms that the patient is not having a hemorrhagic stroke and, therefore, is a good candidate for intravenous r-tPA.

    Researchers compared Kaiser Permanente members treated with intravenous r-tPA in the nine months before September 2015 implementation with those treated in the nine months afterward.

     

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    ED Push

    View PDF
    ED Push - January 2018 Issue
    January 1, 2018

    Table Of Contents

    EDs Should Be Aware of Immune-Related Adverse Events From Cancer Treatment

    Kaiser Permanente Program Slashes ‘Door to Needle’ Time for Stroke Patients

    Errors Significantly Reduced When Pharmacy Staff Takes Medication Histories

    Mysterious Anaphylaxis: When a Steak Dinner Could Be the Cause

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421 x 2

    International +1-404-262-5476 x 2

    Accounts Receivable

    1-800-688-2421 x 3
    ReliasMedia_AR@reliasmedia.com

    Sales

    1-800-688-2421 x 1

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2022 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing